The therapeutic value of physical exercise for people with schizophrenia;De therapeutische waarde van bewegen voor mensen met schizofrenie

Tijdschrift voor Psychiatrie

Volumn 52, Issue 8, 2010, Pages 565-574

  Vancampfort, D ^a   Knapen, J ^a   Probst, M ^a   Van Winkel, R ^a,b   Peuskens, J ^a   Maurissen, K ^a   Demunter, H ^a   De Hert, M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Movement; Psychomotor therapy; Schizophrenia

Indexed keywords

ARTICLE; CARDIOVASCULAR PARAMETERS; EVIDENCE BASED MEDICINE; EXERCISE; HUMAN; METABOLIC PARAMETERS; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL ASPECT; STRESS MANAGEMENT; SYMPTOMATOLOGY; THERAPY EFFECT; COGNITION; KINESIOTHERAPY; PHYSIOLOGY; PSYCHOLOGY; TREATMENT OUTCOME;

COGNITION; EXERCISE; EXERCISE THERAPY; HUMANS; QUALITY OF LIFE; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 77955761625     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Acil, A.A., Dogan, S., & Dogan, O. (2008). The effects of physical exercises to mental state and quality of life in patients with schizophrenia. Journal of Psychiatric and Mental Health Nursing, 15, 808-815.
2. Alvarez-Jimenez, M., Hetrick, S.E., Gonzalez-Blanch, C., e.a. (2008). Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. British Journal of Psychiatry, 193, 101-107.
3. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders. (4de versie). Washington: American Psychiatric Association.
4. Aronne, L.J. (2001). Epidemiology, morbidity, and treatment of overweight and obesity. Journal of Clinical Psychiatry, 62 (Suppl 23), 13-22.
5. Beebe, L.H., Tian, L., Morris, N., e.a. (2005). Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues of Mental Health Nursing, 26, 661-676.
6. Berg, E. van den, Dekker, J.M., Nijpels, G., e.a. (2008). Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study. Dementia and Geriatric Cognitive Disorders, 26, 261-269.
7. Bradshaw, T., Lovell, K., & Harris, N. (2005). Healthy living interventions and schizophrenia: a systematic review. The Journal of Advanced Nursing, 49, 634-654.
8. Brock, C.M., King, D.S., Wofford, M.R., e.a. (2005). Exercise, insulin resistance, and hypertension: a complex relationship. Metabolic Syndrome Related Disorders, 3, 60-65.
9. Brown, S. (1997). Excess mortality of schizophrenia: a meta-analysis. British Journal of Psychiatry, 171, 502-508.
10. Cahn, W., Ramlal, D., Bruggeman, R., e.a. (2008). Preventie en behandeling van somatische complicaties bij antipsychoticagebruik. Tijdschrift voor Psychiatrie, 50, 579-591.
11. Capasso, R.M., Lineberry, T.W., Bostwick, J.M., e.a. (2008). Mortality in schizophrenia and schizoaffective disorder: an Olmsted County, Minnesota cohort: 1950-2005. Schizophrenia Research, 98, 287-294.
12. Carter-Morris, P., & Faulkner, G. (2003). A football project for service users: the role of football in reducing social exclusion. Journal of Mental Health Promotion, 2, 24-30.
13. Casey, D.E., Haupt, D.W., Newcomer, J.W., e.a. (2004). Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. Journal of Clinical Psychiatry, 65 (Suppl 7), 4-18.
14. Citrome, L., & Vreeland, B. (2009). Obesity and mental illness. In J. Thakore & B. Leonard (Red.), Metabolic effect of psychotropic drugs (pp. 25-46). Basel: Karger.
15. Correll, C.U., Frederickson, A.M., Kane, J.M., e.a. (2006). Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. Journal of Clinical Psychiatry, 67, 575-583.
16. Cotman, C.W., Berchtold, N.C., & Christie, L.A. (2007). Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends in Neurosciences, 30, 464-472.
17. Davidson, L.L., & Heinrichs, R.W. (2003). Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Research, 122, 69-87.
18. Donnelly, J.E., Blair, S.N., Jakicic, J.M., e.a. (2009). American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Medicine and Science in Sports and Exercise, 41, 459-471.
19. Duraiswamy, G., Thirthalli, J., Nagendra, H.R., e.a. (2007). Yoga therapy as an add-on treatment in the management of patients with schizophrenia - a randomized controlled trial. Acta Psychiatrica Scandinavica, 116, 226-232.
20. Ellis, N., Crone, D., Davey, R., e.a. (2007). Exercise interventions as an adjunct therapy for psychosis: a critical review. British Journal of Clinical Psychology, 46, 95-111.
21. Faulkner, G. (2005). Exercise as an adjunct treatment for schizophrenia. In G. Faulkner & A. Taylor (Red.) Exercise, health and mental health: Emerging relationships (pp. 27-45). London: Routledge.
22. Faulkner, G. & Biddle, S. (1999). Exercise as an adjunct treatment for schizophrenia: a review of the literature. Journal of Mental Health, 8, 441-457.
23. Faulkner, G., Cohn, T., & Remington, G. (2007). Interventions to reduce weight gain in schizophrenia. Cochrane Database Systematic Reviews, CD005148.
24. Faulkner, G., Cohn, T., & Remington, G. (2006). Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophrenia Research, 82, 225-231.
25. Faulkner, G., & Cohn, T.A. (2006). Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications. Canadian Journal of Psychiatry, 51, 502-511.
26. Fleischhacker, W.W., Cetkovich-Bakmas, M., De Hert, M., e.a. (2008). Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. Journal of Clinical Psychiatry, 69, 514-519.
27. Fogarty, M., & Happell, B. (2005). Exploring the benefits of an exercise program for people with schizophrenia: a qualitative study. Issues in Mental Health Nursing, 26, 341-351.
28. Fujimoto, T., Takeuch, K., Matsumoto, T., e.a. (2007). Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia. Psychiatry Research, 154, 49-58.
29. Green, A.I., Drake, R.E., Brunette, M.F., e.a. (2007). Schizophrenia and co-occurring substance use disorder. The American Journal of Psychiatry, 164, 402-408.
30. Haan, L. de (2009). Bewegen. Tijdschrift voor Psychiatrie, 51, 275-277.
31. Hart, C. (2001). Doing a literarure search. A comprehensive guide for the social sciences. London: Sage Publications.
32. Hasson-Ohayon, I., Kravetz, S., Roe, D., e.a. (2006). Qualitative assessment of verbal and non-verbal psychosocial interventions for people with severe mental illness. Journal of Mental Health, 15, 343-353.
33. Hausswolff-Juhlin, Y. von, Bjartveit, M., Lindstrom, E., e.a. (2009). Schizophrenia and physical health problems. Acta Psychiatrica Scandinavica, 438, 15-21.
34. Heiskanen, T., Niskanen, L., Lyytikainen, R., e.a. (2003). Metabolic syndrome in patients with schizophrenia. Journal of Clinical Psychiatry, 64, 575-579.
35. Hert, M. De, Peuskens, B., Van Winkel, R., e.a. (2006). Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE. Schizophrenia Research, 88, 222-226.
36. Hert, M. De, Schreurs, V., Vancampfort, D., e.a. (2009a). Metabolic syndrome in people with schizophrenia: a review. World Psychiatry, 8, 15-22.
37. Hert, M. De, Dekker, J., Wood, D., e.a. (2009b). Cardiovascular disease and diabetes in people with severe mental illness: Position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry, 24, 412-424.
38. Hillman, C.H., Erickson, K.I., & Kramer, A.F. (2008). Be smart, exercise your heart: exercise effects on brain and cognition. Nature Reviews Neuroscience, 9, 58-65.
39. Kumari, V., & Postma, P. (2005). Nicotine use in schizophrenia: the self medication hypotheses. Neuroscience and Biobehavioral Reviews, 29, 1021-1034.
40. Kwon, J.S., Choi, J.S., Bahk, W.M., e.a. (2006). Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. Journal of Clinical Psychiatry, 67, 547-553.
41. Lindamer, L.A., McKibbin, C., Norman, G.J., e.a. (2008). Assessment of physical activity in middle-aged and older adults with schizophrenia. Schizophrenia Research, 104, 294-301.
42. Marzolini, S., Jensen, B., & Melville, P. (2009). Feasibility and effects of a group-based resistance and aerobic exercise program for individuals with severe schizophrenia: A multidisciplinary approach. Mental Health and Physical Activity, 2, 29-36.
43. Marzolini, S., Oh, P.I., Thomas, S.G., e.a. (2008). Aerobic and resistance training in coronary disease: single versus multiple sets. Medicine and Science in Sports and Exercise, 40, 1557-1564.
44. Meckel, Y., Eliakim, A., Seraev, M., e.a. (2009). The effect of a brief sprint interval exercise on growth factors and inflammatory mediators. Journal of Strength and Condition Research, 23, 225-230.
45. Mustelin, L., Silventoinen, K., Pietilainen, K., e.a. (2009). Physical activity reduces the influence of genetic effects on BMI and waist circumference: a study in young adult twins. International Journal of Obesity (Lond), 33, 29-36.
46. Newcomer, J.W. (2007). Metabolic syndrome and mental illness. American Journal of Managed Care, 13, S170-S177.
47. Osby, U., Correia, N., Brandt, L., e.a. (2000). Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophrenia Research, 45, 21-28.
48. Praag, H. van (2008). Neurogenesis and exercise: past and future directions. Neuromolecular Medicine, 10, 128-140.
49. Rajpathak, S.N., Gunter, M.J., Wylie-Rosett, J., e.a. (2009). The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes and Metabolic Research Reviews, 25, 3-12.
50. Roick, C., Fritz-Wieacker, A., Matschinger, H., e.a. (2007). Health habits of patients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 42, 268-276.
51. Rollins, A., Bond, G., & Lysaker, P. (1999). Characteristics of coping with the symptoms of schizophrenia. Schizophrenia Research, 36, 30.
52. Scheepers-Hoeks, A.M., Wessels-Basten, S.J., Scherders, M.J., e.a. (2008). Schizofrenie en antipsychotica: samenhang met het metabool syndroom. Tijdschrift voor Psychiatrie, 50, 645-654.
53. Schwarz, A.J., Brasel, J.A., Hintz, R.L., e.a. (1996). Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. Journal of Clinical Endocrinology and Metabolism, 81, 3492-3497.
54. Sharpe, J.K., Stedman, T.J., Byrne, N.M., e.a. (2006). Energy expenditure and physical activity in clozapine use: implications for weight management. Australian and New Zealand Journal of Psychiatry, 40, 810-814.
55. Vale, R.G., de Oliveira, R.D., Pernambuco, C.S., e.a. (2009). Effects of muscle strength and aerobic training on basal serum levels of IGF-1 and cortisol in elderly women. Archives of Gerontology and Geriatrics, 49, 343-347.
56. Vancampfort, D., De Hert, M., Knapen, J., e.a. (2009a). Yoga: een nieuwe evidence-based uitdaging voor de psychomotorische therapie bij mensen met schizofrenie. In J. Simons (Red.), Actuele themata uit de psychomotorische therapie (pp. 53-72). Leuven: Acco.
57. Vancampfort, D., Knapen, J., Rutten, L., e.a. (2009b). Motiveren tot bewegen binnen de psychomotorische therapie. In J. Simons (Red.), Actuele themata uit de psychomotorische therapie. (pp. 11-40). Leuven: Acco.
58. Venkatasubramanian, G., Chittiprol, S., Neelakantachar, N., e.a. (2007). Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia. The American Journal of Psychiatry, 164, 1557-1560.
59. Wang, Z., Heshka, S., Zhang, K., e.a. (2001). Resting energy expenditure: systematic organization and critique of prediction methods. Obesity Research, 9, 331-336.
60. Wu, M.K., Huang, C.Y., Liou, Y.J., e.a. (2008). Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity. International Journal of Obesity (Lond), 32, 436-442.
61. Wu, M.K., Wang, C.K., Bai, Y.M., e.a. (2007). Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatric Services, 58, 544-550.
62. Yaffe, K. (2007). Metabolic syndrome and cognitive decline. Current Alzheimer Research, 4, 123-126.
63. Yates, T., Khunti, K., Bull, F., e.a. (2007). The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia, 50, 1116-1126.